Spanish Gene Therapy for Alzheimer's Enters Human Trials in Australia

Tetraneuron, a Spanish biotech, received approval to start human trials in Australia for TET-101, a gene therapy targeting moderate Alzheimer's. The company also secured over €4.3 million in public funding. This moves a new mechanism against neurodegeneration closer to patients.